Drug Administration Law of the People's Republic of China (Revised in 2015)

Drug Administration Law of the People's Republic of China (Revised in 2015)
Drug Administration Law of the People's Republic of China (Revised in 2015) 

Order of the President of the People's Republic of China No.27

April 24, 2015

(Adopted at the Seventh Meeting of the Standing Committee of the Sixth National People's Congress on September 20, 1984
Revised at the 20th Meeting of the Standing Committee of the Ninth National People's Congress on February 28, 2001
Revised according to the Decision of the Standing Committee of the National People's Congress on Amending Seven Laws Including the Law of the People's Republic of China on the Protection of the Marine Environment at the 6th Meeting of the Standing Committee of the 12th National People's Congress on December 28, 2013
Revised according to the Decisions of the Standing Committee of the National People's Congress on Revising the Drug Administration Law of the People's Republic of China at the 14th Meeting of the Standing Committee of the 12th National People's Congress on April 24, 2015)

Contents
Chapter I General Provisions
Chapter II Administration over Drug Manufacturers
Chapter III Administration over Drug Distributors
Chapter IV Administration over Pharmaceuticals in Medical Institutions
Chapter V Administration over Drugs
Chapter VI Administration over Drug Packaging
Chapter VII Administration over Drug Pricing and Advertising
Chapter VIII Supervision over Drugs
Chapter IX Legal Liabilities
Chapter X Supplementary Provisions

Chapter I General Provisions

Article 1 The Drug Administration Law of the People's Republic of China (hereinafter referred to as the "Law") is enacted to strengthen drug supervision and administration, to ensure drug quality and safety for human beings, and to protect the health of the people and their legitimate rights and interests in the use of drugs.

Article 2 All entities and individuals engaged in research, production, distribution and use of, and supervision and administration over, drugs within the territory of the People's Republic of China shall abide by the Law.

Article 3 The State develops both modern and traditional medicines to give full play to their role in prevention and treatment of diseases and in maintenance of health.
The State protects the resources of natural crude drugs and encourages the cultivation of traditional Chinese drugs.

Article 4 The State encourages the research and development of new drugs and protects the legitimate rights and interests of citizens, legal persons and other organizations engaged in this field of endeavor.

Article 5 The drug regulatory department under the State Council is responsible for drug supervision and administration nationwide.
  ......